Laurence Maynard
Overview
Explore the profile of Laurence Maynard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonneau S, Maynard L, Tomczuk K, Kok D, Eun H
Parasitol Res
. 2009 Jun;
105(3):817-23.
PMID: 19488785
In this blinded randomized and controlled study, the anthelmintic efficacy of a tablet formula of ivermectin-praziquantel was evaluated in horses experimentally infected with three species of Strongylus larvae. Eighteen previously...
2.
Woerly V, Maynard L, Sanquer A, Eun H
Parasitol Res
. 2009 Mar;
105(2):463-9.
PMID: 19322588
The study was aimed to assess the efficacy and tolerance profiles of an oral administration miltefosine drug (Milteforan(R), Virbac) in dogs with natural leishmaniosis. In this multicentric open trial, 96...
3.
Mateo M, Maynard L, Vischer C, Bianciardi P, Miro G
Parasitol Res
. 2009 Feb;
105(1):155-62.
PMID: 19238439
The aim of this study was to compare the efficacy and safety of oral administration of miltefosine (Milteforan) at 2 mg/kg/day for 28 days (Group M; n = 60) with...
4.
Volkow N, Wang G, Franceschi D, Fowler J, Thanos P, Maynard L, et al.
Neuroimage
. 2005 Aug;
29(1):295-301.
PMID: 16085426
Moderate doses of alcohol decrease glucose metabolism in the human brain, which has been interpreted to reflect alcohol-induced decreases in brain activity. Here, we measure the effects of two relatively...
5.
de Mari K, Maynard L, Sanquer A, Lebreux B, Eun H
J Vet Intern Med
. 2004 Aug;
18(4):477-82.
PMID: 15320583
The clinical efficacy of a recombinant feline interferon, rFeIFN-omega, was evaluated for the treatment of cats presented with clinical signs associated with feline leukemia virus (FeLV) infection and FeLV/feline immunodeficiency...
6.
Volkow N, Wang G, Fowler J, Telang F, Maynard L, Logan J, et al.
Am J Psychiatry
. 2004 Jul;
161(7):1173-80.
PMID: 15229048
Objective: Methylphenidate is the most commonly prescribed drug for attention deficit hyperactivity disorder (ADHD), yet its therapeutic mechanisms are poorly understood. The objective of this study was to assess if...
7.
Volkow N, Wang G, Ma Y, Fowler J, Zhu W, Maynard L, et al.
J Neurosci
. 2003 Dec;
23(36):11461-8.
PMID: 14673011
The reinforcing effects of drugs of abuse result from the complex interaction between pharmacological effects and conditioned responses. Here we evaluate how expectation affects the response to the stimulant drug...
8.
Volkow N, Wang G, Maynard L, Jayne M, Fowler J, Zhu W, et al.
Int J Eat Disord
. 2003 Mar;
33(2):136-42.
PMID: 12616579
Objective: Eating behavior in humans is influenced by variables other than just hunger-satiety including cognitive restraint, emotional distress, and sensitivity to food stimuli. We investigate the role of dopamine (DA),...
9.
Volkow N, Wang G, Fowler J, Logan J, Franceschi D, Maynard L, et al.
Synapse
. 2002 Jan;
43(3):181-7.
PMID: 11793423
Methylphenidate (Ritalin) is an effective drug in the treatment of attention deficit hyperactivity disorder. However, the doses required therapeutically vary significantly between subjects and it is not understood what determines...